These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3209298)

  • 21. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts.
    Andrew SM; Perkins AC; Pimm MV; Baldwin RW
    Eur J Nucl Med; 1988; 13(11):598-604. PubMed ID: 3350036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
    Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
    Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of tumor CEA content and tumor size on tissue uptake of indium 111-labeled anti-CEA monoclonal antibody.
    Philben VJ; Jakowatz JG; Beatty BG; Vlahos WG; Paxton RJ; Williams LE; Shively JE; Beatty JD
    Cancer; 1986 Feb; 57(3):571-6. PubMed ID: 3942992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS
    Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.
    Roselli M; Schlom J; Gansow OA; Raubitschek A; Mirzadeh S; Brechbiel MW; Colcher D
    J Nucl Med; 1989 May; 30(5):672-82. PubMed ID: 2785585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The localization of human breast carcinomas by radiolabelled monoclonal antibodies.
    Rainsbury RM
    Br J Surg; 1984 Oct; 71(10):805-12. PubMed ID: 6237710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.
    Pimm MV; Armitage NC; Perkins AC; Smith W; Baldwin RW
    Cancer Immunol Immunother; 1985; 19(1):8-17. PubMed ID: 3844977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretargeted tumour imaging with streptavidin immunoconjugates of monoclonal antibody CC49 and 111In-DTPA-biocytin.
    Alvarez-Diez TM; Polihronis J; Reilly RM
    Nucl Med Biol; 1996 May; 23(4):459-66. PubMed ID: 8832700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of radiosensitizers on radio-immunotherapy, using 131I-labelled anti-CEA antibodies in a human colonic xenograft model.
    Pedley RB; Begent RH; Boden JA; Boden R; Adam T; Bagshawe KD
    Int J Cancer; 1991 Feb; 47(4):597-602. PubMed ID: 1995488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo].
    Sun B
    Kaku Igaku; 1994 May; 31(5):473-87. PubMed ID: 8028219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New chelating agent for attaching indium-111 to monoclonal antibodies: in vitro and in vivo evaluation.
    Subramanian R; Colony J; Shaban S; Sidrak H; Haspel MV; Pomato N; Hanna MG; McCabe RP
    Bioconjug Chem; 1992; 3(3):248-55. PubMed ID: 1520729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft.
    Stribbling SM; Martin J; Pedley RB; Boden JA; Sharma SK; Springer CJ
    Cancer Chemother Pharmacol; 1997; 40(4):277-84. PubMed ID: 9225945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of 111In-labelled monoclonal antibody ZCE-025 and fragments in tumour-bearing mice.
    Koziol JA; Lee PP; Dillman RO; Fagnani R; Halpern SE
    Nucl Med Commun; 1995 Apr; 16(4):299-305. PubMed ID: 7624111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.
    Lewis MR; Raubitschek A; Shively JE
    Bioconjug Chem; 1994; 5(6):565-76. PubMed ID: 7873659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft.
    Pedley RB; Boden J; Keep PA; Harwood PJ; Green AJ; Rogers GT
    Eur J Nucl Med; 1987; 13(4):197-202. PubMed ID: 3040415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of specific antibody pretreatment on liver uptake of 111In-labeled anticarcinoembryonic antigen monoclonal antibody in nude mice bearing human colon cancer xenografts.
    Beatty BG; Beatty JD; Williams LE; Paxton RJ; Shively JE; O'Connor-Tressel M
    Cancer Res; 1989 Mar; 49(6):1587-94. PubMed ID: 2924309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative distribution study of 111In-labeled DTPA and TTHA monoclonal antibody conjugates in a choriocarcinoma xenograft model.
    Buckley RG; Barnett P; Searle F; Pedley R; Boden JA
    Eur J Nucl Med; 1986; 12(8):394-6. PubMed ID: 3098566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbohydrate-derivatized immunoconjugate of the anti-(carcinoembryonic antigen) monoclonal antibody C46: immunohistological reactivity and pharmacokinetic comparison with a randomly derivatized C46 immunoconjugate.
    Rosenstraus MJ; Davis WL; Lopes AD; D'Aleo CJ; Gilman SC
    Cancer Immunol Immunother; 1990; 32(4):207-13. PubMed ID: 2261596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.